Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 07, 2022

BUY
$1.9 - $8.63 $57,000 - $258,900
30,000 New
30,000 $74,000
Q2 2022

Aug 11, 2022

SELL
$2.13 - $9.01 $42,600 - $180,200
-20,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$6.28 - $15.59 $125,600 - $311,800
20,000 New
20,000 $159,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Warberg Asset Management LLC Portfolio

Follow Warberg Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warberg Asset Management LLC with notifications on news.